SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-017834
Filing Date
2022-06-27
Accepted
2022-06-27 16:15:18
Documents
13
Period of Report
2022-06-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46819
  Complete submission text file 0001493152-22-017834.txt   264867

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ensc-20220627.xsd EX-101.SCH 3704
3 XBRL DEFINITION FILE ensc-20220627_def.xml EX-101.DEF 26619
4 XBRL LABEL FILE ensc-20220627_lab.xml EX-101.LAB 36693
5 XBRL PRESENTATION FILE ensc-20220627_pre.xml EX-101.PRE 25243
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5560
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 221044723
SIC: 2834 Pharmaceutical Preparations